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ABSTRACT 
 
 
Cellular FLICE-inhibitory proteins (c-FLIPs) regulate Death Receptor (DR)-induced 
apoptotic as well as non-apoptotic pathways, by modulating caspase-8 activation. Here we 
showed that the long isoform of c-FLIP unexpectedly controls the Endoplasmic Reticulum 
(ER) morphology and the physical and functional crosstalk between ER and mitochondria. 
Besides its previously described cytosolic localization, we observed that c-FLIPL is also 
retrieved at the ER and Mitochondria-associated membranes (MAMs), ER subdomains 
involved in the ER-to-mitochondria Ca
2+
 transport, lipid metabolism and ER stress-induced 
apoptosis. We demonstrated that the ablation of c-FLIPL in mouse embryonic fibroblasts 
(MEFs) specifically alters ER morphology, inducing ER-sheets proliferation and altering the 
luminal contiguity of this organelle. Re-introduction of c-FLIPL in c-FLIP
-/-
 cells partially 
recovers these structural defects, therefore confirming the role of c-FLIPL in modulation of 
ER morphology. In agreement, we also reported that c-FLIP
-/-
 MEFs show reduced expression 
of the ER shaping protein reticulon4 (RTN4), that is mainly known as regulator of ER 
biogenesis and dynamics. Furthermore, we observed that c-FLIPL ablation loosens ER-
mitochondria juxtaposition. We demonstrated that functionally, c-FLIPL ablation lowers the 
cytosolic Ca
2+
-increase evoked either by agonist stimulation or passive ER discharge. 
Furthermore, c-FLIP
-/-
 cells are more resistant than their WT counterpart to cell death induced 
by the ER stress inducers thapsigargin and tunicamycin. Taken together, our findings suggest 
a novel role for c-FLIP as regulator of ER function and ER-mitochondria crosstalk.   
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INTRODUCTION 
 
 
1. APOPTOSIS 
 
Apoptosis was firstly described as physiologically controlled cell death in 1972 [1].  
Apoptosis regulates several cellular processes, such as cell turnover and embryonic 
development, and its dysregulation is implicated in different disease states. Cells undergoing 
apoptosis exhibit a characteristic pattern of morphological changes, including cell shrinkage, 
membrane blebbing, DNA fragmentation and phosphatidylserine exposure [2]. The apoptotic 
process relies on the action of caspases, a family of aspartate-specific cysteine proteases, 
which cleave essential cellular proteins. Caspases initiate and execute cell death through a 
two-step mechanism in which initiator caspases (caspase-8, -9 and -10) cleave and activate 
the effector caspases (caspase-3, -6 and -7), which in turn cleave several distinct substrates to 
realize the apoptotic program [3]. Two major signaling pathways ensure proper execution of 
apoptosis, the extrinsic and the intrinsic pathway (Fig. 1) [4]. They are both initiated by the 
assembly of activating molecular platforms and the consequent recruitment and, local 
increase, in initiator caspases, therefore causing their activation through a process referred to 
as “ induced proximity” [5]. 
 
1.1 The intrinsic pathway  
 
The intrinsic pathway, also known as the mitochondrial pathway, is activated by stimuli that 
lead to mitochondrial outer membrane permeabilization (MOMP) and the release of proteins 
from the mitochondrial intermembrane space (IMS), including cytochrome c. In the cytosol, 
the cytochrome c engages APAF1 (apoptotic protease-activating factor-1) to form  the 
apoptosome, an oligomeric signaling platform that brings together several molecules of 
caspase-9, the initiator caspase of the intrinsic pathway, enabling their autoactivation and 
cleavage of a large array of substrates. Apoptosis is a highly regulated process and various 
inhibitors specific for both the intrinsic and extrinsic pathway have been characterized. The 
most important regulators of mitochondrial apoptosis are members of the B-cell lymphoma 
protein-2 (BCL2) family. Among these, anti-apoptotic proteins such as Bcl-2 and Bcl-XL 
prevent activation and oligomerization in the outer mitochondrial membrane (OMM) of the 
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pro-apoptotic members of BCL2 family Bid, Bax and Bak, which in turn promote the 
formation of large openings in the OMM and the release of cytochrome c and other pro-
apoptotic factors from the IMS to cytosol [6]. 
 
1.2 The extrinsic pathway 
 
The extrinsic pathway is initiated by the engagement of surface receptors of death receptor 
(DR) family by their ligands. All DRs belong to the tumor necrosis factor (TNF) receptor 
superfamily, and they are characterized by an extracellular domain consisting of a variable 
number of cysteine-rich repeats and a protein-protein intracellular interaction motif named 
death domain (DD) in their cytoplasmic tail [7]. The best characterized DRs are the apoptosis 
stimulating fragment (CD95/Fas), the TNF receptor 1 (TNFR1) and the TNF-related 
apoptosis-inducing ligand receptor 1 (TRAILR1) [8]. Triggering of CD95/Fas by its ligand 
CD95L/FasL induces the formation of a multimolecular complex of proteins termed death-
inducing signaling complex (DISC) which consists of trimerized receptors, the Fas-
Associated Death Domain (FADD) adaptor protein, the initiator caspase, procaspase-8 (or 
procaspase-10) and the cellular FLICE inhibitory protein (c-FLIP). FADD, which contains a 
C-terminal DD and an N-terminal death effector domain (DED), interacts via its DDs with the 
receptor, whereas DEDs are necessary to the homotypic interaction with procaspase-8, 
procaspase-10 and c-FLIP DEDs. At the DISC level, severale procaspase-8 molecules are 
recruited, thus favoring their auto-cleavage and activation and thereby leading to the 
triggering of the apoptotic signal. [9, 10]  
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Figure 1: Intrinsic versus extrinsic apoptotic pathways [4]. 
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2. CELLULAR FLICE INHIBITORY PROTEINS (c-FLIP) 
 
2.1 Structure and function in apoptosis 
 
 After the characterization of caspase-8 and -10 and FADD as DED-containing proteins, other 
proteins structurally similar to the prodomain of caspase-8 were identified in several 
herpesvirus [11]. They are collectively known as viral FLIP inhibitory proteins (v-FLIPs). 
Shortly after their identification, human cellular homologues of v-FLIP were described by 
different groups and they have been termed cellular FLICE inhibitory protein (c-FLIP) [12, 
13]. The gene encoding c-FLIP is called CFLAR (CASP8 and FADD-like apoptosis 
regulator). It is located on human chromosome 2q33, together with caspase-8 and -10, 
suggesting that these three genes arose by gene duplication [12]. Three different splice 
variants of c-FLIP have been described at the protein level: c-FLIPS (27kDa), c-FLIPR 
(25kDa) and c-FLIPL (55kDa) [12, 14]. All isoforms contain two DED motifs at their N-
terminal, that is structurally similar to the N-terminal part of procaspase-8 (Fig. 2).  
 
 
c-FLIPL is identical in length with caspase-8 and contains a caspase-like domain, that is 
catalytically inactive, at its C-terminal. By contrast, c-FLIPS and c-FLIPR present tandem 
DED motifs followed by a short and variable stretch of aminoacids at the C-terminal tail [10]. 
Besides full length isoforms of c-FLIP, cleavage products of this protein have been detected at 
the protein level as well. Active caspase-8 cleaves c-FLIPL at Asp-376 in the caspase-like 
domain, generating the so-called p43 fragment; procaspase-8 cleaves c-FLIPS,R,L on Asp-196, 
generating a cleavage product, called p22, containing the tandem DED motif. Active caspase-
8 and procaspase-8 show mutually exclusive proteolytic specificity on these two cleavage 
sites [15, 16]. The three isoforms show differences in localization and functions. c-FLIPL 
 
 
Figure 2: c-FLIP isoforms and cleavage products [10]. 
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localizes in the nucleus and cytoplasm, whereas c-FLIPS,R predominantly localize in the 
cytoplasm [17, 18]. All isoforms are recruited at the DISC in the early stages of death 
receptor-mediated apoptosis. At the DISC, c-FLIP interacts with FADD, preventing the 
interaction between FADD and procaspase-8 and blocking the transduction of the apoptotic 
signal. It has been reported that all isoforms strongly associate with FADD through their DED 
motifs, whereas the caspase-like domain of c-FLIPL is by contrast necessary to the interaction 
with both procaspase-8 and active caspase-8 [12, 19]. Although v-FLIP and c-FLIPS,R are 
widely accepted as anti-apoptotic proteins, the role of c-FLIPL is still unclear. Indeed, besides 
its anti-apoptotic function, a pro-apoptotic role depending on caspase-8:c-FLIPL ratio has also 
been reported (Fig. 3) [20-22]. At lower, physiological concentrations, c-FLIPL 
heterodimerizes with both procaspase-8 and caspase-8. Heterodimerization allows the 
allosteric activation of procaspase-8, promoting the initial processing of caspase-8, but 
restricting its activity below a threshold such that the fully active caspase-8 is not formed. 
Moreover, caspase-8/c-FLIPL heterodimers are confined to the DISC and process only 
proximal substrates such as the receptor-interacting protein (RIP) and c-FLIPL itself, which is 
cleaved to the p43 fragment. These findings suggest that a complete block of caspase-8 
activity is not advisable, and hypothesize alternative apoptosis-independent activities of 
caspase-8. At moderate expression levels, found in some tumors and cell lines, c-FLIPL acts 
as an inhibitor of DR-mediated apoptosis. Conversely, when highly overexpressed, c-FLIPL 
results cytotoxic by itself, probably through the association with caspase-8 outside the DISC.  
 
 
 
Figure 3: Controversial functions of c-FLIPL [23]. 
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2.2 Non apoptotic function of c-FLIP 
 
In addition to their function in apoptosis signaling, c-FLIP, FADD  and procaspase-8 are also 
critical mediators of cell survival and proliferation, particularly in lymphocytes. Ablation of 
any of these genes yields embryonic lethality in mice. Knockout mice for c-FLIPL have 
defects similar to FADD and caspase-8 knockout and are characterized by heart failure and 
death at embryonic day 10.5, thus suggesting a potential pro-apoptotic role of c-FLIPL [25]. A 
common non-apoptotic function for DED proteins has been also confirmed in conditionally 
depleted, murine T cell, which resulted incapable to proliferate upon T-cell receptor 
stimulation (Reviewed in [24]). In accordance, both c-FLIPL and partially active procaspase-8 
can promote the NF-kB pathway, inducing cells survival and proliferation [26].  
Heterodimerization of the two proteins and caspase-b mediated cleavage of c-FLIP to form 
the p43 and p22 fragments could explain NF-kB induction. In fact, both cleavage products 
could interact with proteins regulating the NF-kB pathway, therefore strongly promoting NF-
kB activation (Fig.4) (Reviewed in [24]). 
 
 
Figure 4: Proteolytic cleavage of c-FLIP by procaspase-8 and its role in NF-kB pathway [24]. 
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3. TYPE I AND II CELLS IN THE FAS SIGNALING 
 
Although the extrinsic and intrinsic pathways act independently, it is now clear that in some 
circumstances the DRs pathway relies on the amplification of death signals mediated by the 
mitochondrial pathway. On the base of the dependence of the death receptor-mediated 
apoptotic signal on the intrinsic pathway, Fas-expressing cells and tissues are classified as 
type I or II [27]. Type I cells, such as lymphocytes, bypass the need for mitochondrial 
amplification in Fas-mediated apoptosis by producing large amounts of DISC and therefore 
activating caspase-8, which can in turn directly activate the executioner caspases. By contrast, 
type II cells generate very little active caspase-8 at the DISC and they completely rely on the 
intrinsic pathway. Indeed, the small quantity of active caspase-8 is unable to induce apoptosis, 
but is sufficient to cleave the pro-apoptotic BH3-only protein of the BCL2 family Bid. 
Truncated Bid (tBid) translocates to mitochondria where it activates other two pro-apoptotic 
member of BCL2 family Bax and Bak, inducing mitochondrial permeabilization, which 
ultimately enhances the apoptotic signal [28].  
 
3.1 Lipid rafts involvement in modulation of Fas signaling  
 
Recently, this model has been refined by the finding that, following receptor stimulation, 
members of TNFR family are recruited to membrane subdomains called lipid rafts (LRs). The 
different efficiency of Fas signaling in type I and II cells can hence depends on receptor 
submembrane localization [29]. In particular, it has been demonstrated that in type I cells, Fas 
partially resides constitutively in LRs, while it is excluded from these microdomains in type II 
cells. LRs could therefore sensitize type I cells by acting as signaling platforms where Fas 
receptor is partially pre-associated, thus easily recruiting and activating DISC components. By 
contrast, in type II cells Fas is not pre-associated, but it is recruited to, after stimulation [30]. 
Proteins that are N-myristoylated and/or S-palmitoylated partition into membrane rafts. It has 
been hence hypothesized that Fas palmitoylation on cysteine 199 is involved in the 
recruitment of the receptor into LRs and in its efficient aggregation, that is a mandatory step 
in triggering cell death [31]. 
More recently, the ability of other DISC components such as caspase-8 and c-FLIPL to 
redistribute to LRs, after T cell activation, has been reported [32]. This model suggests that 
TCR-induced caspase-8 activation occurs in a sequestered environment that limits the degree 
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of caspase-8 activation as well as restricts the cleavage of caspase-8 substrates to those not 
necessarily involved in cell death execution. The occurrence of Fas signaling in sequestered 
membrane LRs could influence the efficiency of signaling and limit caspase-8 activity to local 
substrates, therefore contributing to explain the controversial role of DRs signaling and DISC 
components in regulation of both apoptosis and proliferation. 
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4. LOCAL COMPLEXES OF CASPASE-8 ACTIVATION 
 
In the last years, the importance of intracellular protein complexes and their localization in 
modulating cellular functions has emerged. Regarding components of the DISC, it is now 
clear that both FADD and procaspase-8/caspase-8 can associate to intracellular organelles 
such as mitochondria and endoplasmic reticulum (ER), where they seem to be recruited in 
local complexes to regulate not only the apoptotic response following DRs engagement, but 
also ER stress and ER-mitochondria crosstalk.  
 
4.1 Recruitment on mitochondrial signaling platforms: the role of cardiolipin 
 
Even though procaspase-8 and caspase-8 were mostly considered cytosolic proteins, their 
association to mitochondrial outer membrane (OMM) was also described [33, 34]. More 
recently, it has been demonstrated that the mitochondrial phospholipid cardiolipin (CL) 
induces caspase-8 accumulation and processing at the mitochondrial outer membrane [35]. 
CL is a mitochondrial, anionic phospholipid, that is enriched in internal mitochondrial 
membrane (IMM) and at the contact sites between the inner and outer membranes of these 
organelles. CL has been shown to associate with members of the apoptotic machinery, such as 
cytochrome c and members of BCL-2 family (Reviewed in [36]). Furthermore, CL serves as 
docking site for tBid on the mitochondrial membrane [37] and regulates Bax oligomerization 
and MOMP [38]. In type II cells CL is necessary to the formation of an apoptotic signaling 
complex where several molecules of procaspase-8 cluster and are activated by proximity upon 
Fas stimulation [35]. This “compartimentalized” processing of caspase-8 indicates that the 
activation of a caspases-cascade on local signaling platforms such as mitochondria, could 
promote the cleavage of specific substrates where they are necessary: along CL docking sites 
on mitochondria, caspase-8 activates Bid directly on the surface of its target organelle, thus 
promoting Bax and Bak oligomerization, cytochrome c release and apoptosis (Fig. 5) [39]. 
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4.2 Recruitment on ER signaling platforms: the role of Bap31 
 
Among locally-cleaved caspase-8 substrates, it has been identified the ER resident protein 
Bap31 [40]. Bap31 is an ER integral membrane protein, that binds to nascent membrane 
proteins in transit between ER and cis-Golgi. In response to the oncogenic adenovirus E1A 
and Fas ligand, Bap31 forms a signaling complex in the ER including Bcl-2/Bcl-XL and the 
isoform of procaspase-8, procaspase-8L [40, 41]. The cytosolic tail of Bap31 indirectly 
interacts with caspase-8, that in turn, cleaves Bap31 on two cleavage sites. Although the full 
length Bap31 acts as a direct inhibitor of caspase-8, when it is cleaved by this caspase, the 
truncated, membrane-embedded p20, fragment by contrast acts a potent apoptosis inducer. 
BCL2-family proteins are localized both at the ER and mitochondria [42] and the association 
of Bap31 with both procaspase-8 and Bcl-2/Bcl-XL raises the possibility that the Bap31 
complex in the ER cooperates with mitochondria in the modulation of a Bcl-2-regulated 
caspase-cascade. In agreement, the caspase-resistant Bap31 (crBap31) provides resistance to 
Fas-mediated apoptosis, preventing mitochondrial remodeling and cytochrome c release, 
although procaspase-8 and Bid activation seems not to be influenced [43]. Cleavage of Bap31 
at the ER therefore, appears to support the mitochondrial step following Fas stimulation, 
suggesting that events at the ER can influence those mitochondrial modifications which 
sustain apoptotic responses (Fig. 6). More recently, it has been observed that the p20 fragment 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Localized production of active, cleaved Bid on cardiolipin platforms [39]. 
12 
 
mediates the Ca
2+
-dependent ER-mitochondria crosstalk, suggesting that efficient Fas 
signaling requires Ca
2+
-release from the ER  [44]. In fact, after Fas stimulation, the p20 
fragment promotes mitochondrial fragmentation mediated by the dynamin related protein 1 
(Drp1). However, Bax activation and cytochrome c release are delayed, thus suggesting that 
Ca
2+
-dependent signals from ER sensitize mitochondria to the following caspase-8 mediated 
cleavage of Bid, that in turn, cooperates in the activation of mitochondrial steps in Fas 
signaling [45].  
 
 
 
 
 
 
Figure 6: Proposed mode of action of Bap31 fragment p20 [44]. 
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4.3 Recruitment on ER signaling platforms: the role of reticulon 3 
 
In the last years, the subcellular localization of FADD has also been investigated, confirming 
that, as for caspase-8/procaspase-8 and c-FLIP, besides its cytosolic localization, FADD 
distributes in the nucleus too [46]. More recently, it has been also described the ability of 
FADD to localize at the ER upon stimulation of extracellular signals [47], therefore 
confirming the hypothesis that members of the DRs signaling form intracellular complexes 
not confined to the plasma membrane. Recruitment of FADD on the ER depends on the 
interaction between the DD of FADD and the C-terminal domain of members of the reticulon 
(RTN) family, in particular RTN3 and RTN4B. RTNs are proteins mainly resident in the ER, 
involved in several functions such as regulation of ER morphology and ER stress response 
[48]. Treatment with the ER stress inducer tunicamyn, increases this interaction, suggesting 
that treatments that alter ER equilibrium and cause cell death, can promote the RTN3-
dependent recruitment of FADD in ER-bound complexes and the subsequent local activation 
of caspase-8 and cytochrome c release. The dominant-negative of FADD (DN-FADD) 
impairs the interaction with RTN3, therefore inhibiting caspase-8 activation and Bid cleavage. 
Conversely no alterations in Bap31 cleavage are reported, indicating that the RTN3/FADD-
mediated activation of caspase-8 could be parallel to Bap31 pathway and highlighting the 
possibility that RTN3 acts as sensor of the ER functionality. 
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5. THE EMERGING ROLE OF ER-MITOCHONDRIA CROSSTALK  IN 
APOPTOSIS 
 
The importance of subcellular organelles such as mitochondria, ER and the Golgi in the 
progression of cell death programs, is emerging. As previously described, recent findings 
suggest that Fas signaling execution depends on complexes localized in ER and mitochondria, 
or on lipid rafts in the plasma membranes (PM), where components of the DISC are recruited 
and activated. Intracellular LRs, different in composition from those in the PM have been 
found both in the ER [49] and mitochondria [50]. In particular, raft-like microdomains 
localize at the interface between these two organelles, participating in the regulation of ER-
mitochondria crosstalk and in the trafficking pathways associated with cell death [51]. ER-
mitochondria interactions take place at specific “contact points” between ER membranes and 
the OMM, known as mitochondria-associated membranes (MAMs) [52]. Very recently, 
MAMs have been described as LR-like domains [53, 54], enriched in proteins and lipids 
necessary to physical and functional coupling of ER and mitochondria [55]. In the last years, 
the role of ER-mitochondria crosstalk in the regulation of apoptosis has gained increasing 
importance. On the ER several pro- and anti-apoptotic mechanisms converge to mediate cell 
stress responses. In this regards, calcium storage and handling, which take place in the ER, are 
particularly significant. For example, proteins of the BCL2 family, that are key components of 
the intrinsic apoptosis, also exert housekeeping functions in the ER, controlling Ca
2+
 
homeostasis, protein folding and apoptosis execution [56] (See below for a thorough 
description). In particular, Bcl-2, Bax and Bak modulate resting ER Ca
2+
 levels and ER-
mitochondria Ca
2+
 exchange, thus influencing the apoptotic response [57, 58]. Moreover, 
BH3-only proteins of BCL2 family influence the signaling between ER and mitochondria 
during the unfolded protein response (UPR) associated to the accumulation of unfolded 
proteins in the ER and the consequent alteration of the ER homeostasis (a condition called ER 
stress). These findings confirm the importance of ER-to-mitochondria communications in the 
regulation of Ca
2+
-exchange and apoptosis. Moreover, they indicate that mediators enriched 
or recruited at the membranes of these organelles can act promoting the exchange of signals 
between ER and mitochondria, hence influencing pathways converging in the modulation of  
cell fate. 
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6. THE ENDOPLASMIC RETICULUM 
 
The endoplasmic reticulum is a large membranous organelle that spreads throughout the 
cytoplasm from the nucleus, reaching to the plasma membrane (PM). It was firstly identified 
in 1945 on electron micrographs [59] and successively divided into two types, smooth and 
rough ER, based on the presence of bound ribosomes and polysomes [60]. Later on, it was 
discovered that the nuclear envelope (NE) was another domain of the ER [61]. The ER is a 
continuous membrane system organized in sheet-like structures, including the nuclear 
envelope, and in a network of tubules that branch at tripartite junctions to generate a 
polygonal meshwork, extended throughout the periphery of the cell [62]. It is a unique 
organelle because of its size, plethora of functions and its ability to interact with virtually all 
other intracellular organelles. Reflecting these numerous functions, the ER is organized in 
spatially and functionally distinct subdomains, characterized by a unique set of specialized 
proteins, some of which characteristically targeted to these domains by intra-ER targeting 
signals or post-translational modifications (Reviewed in [63]). As already reported, the first 
subdivision of the ER was originally in smooth or rough ER [64]. 
The rough ER (RER) is characterized by the presence of bound ribosomes and protein 
translocation channels (translocons). It is involved in the synthesis and post-translational 
modification of secretory and membrane proteins. It also contains ER chaperones and 
oxidoreductases, assisting the folding of newly synthesized proteins (Fig. 7). The nuclear 
envelope is contiguous with the rough ER but presents bound ribosomes only on the cytosolic 
face (Fig. 7). It is characterized by specific integral membrane proteins connecting the inner 
nuclear membrane to chromatin or nuclear lamina and proteins bridging it to the cytoskeleton 
(Reviewed in [63]). Both RER and nuclear envelope have a sheet-like appearance with low 
membrane curvature that allows ribosomes and translocons binding [65]. The smooth ER 
(SER) is devoid of ribosomes [60] and it is shaped as smooth tubules (Fig. 7). It is organized 
in different specialized subdomains including the ER exit sites (ERES), the plasma 
membrane-associated ER (PAM) and the ER quality control compartment (ERQC). 
Specialized enzymes and proteins localize at these functionally distinct subdomains in the 
smooth ER, thus confirming the existence of intra-ER targeting signals [66]. One of the major 
functions of the SER is the storage and handling of calcium. In fact, the inositol 1,4,5-
trisphosphate receptors (IP3Rs) and ryanodine receptor calcium channels (RyRs) cluster 
within the smooth ER [67], forming sub-compartments devoted to Ca
2+
 homeostasis [68] and 
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mobilization toward other ER-interacting organelles such as mitochondria and the plasma 
membrane (Fig. 7).  
 
 
 
6.1 Mechanisms regulating ER dynamics 
 
Mechanisms of organelle shaping exist and regulate ER dynamics, promoting the formation 
of sheet-like structures or interconnected tubules, which share a single and continuous lumen, 
but accommodate distinct physiological functions, hence guaranteeing the maintenance of the 
multifunctionality of this organelle. In particular, flattened sacks typical of cisternal ER are 
better suited for ribosome binding and association of translocation machinery, therefore 
characterizing the RER. Conversely, tubular ER, that mainly features the SER, presents 
multiple regions of high membrane curvature, that better accommodate rapid calcium 
signaling and membrane traffic (Reviewed in [70]). Moreover, the ER structure is constantly 
remodeled. This dynamic behavior reflects its ability to adapt to constantly changing cellular 
requirements relying on rapid ER restructuring and on partitioning of particular proteins. Even 
though mechanisms regulating ER dynamics are still not fully understood, great advances 
have been made in the last years, identifying some of the proteins involved in ER membrane 
biogenesis and remodeling. Among mechanisms responsible for organelle shaping, a 
fundamental role has been attributed to the so-called ER-shaping proteins. Members of the 
RTN (reticulon), DP1 (Deleted in Polyposis Locus Protein 1) and atlastin (ATL) families 
 
 
Figure 7: Structural and functional heterogeneity of the ER [69]. 
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regulate tubule formation and fusion. By contrast, morphology of cisternae is modulated by 
the sheet-enriched proteins 63-kDa cytoskeleton-linking membrane protein (CLIMP63), p180 
and kinectin. 
 
 
6.2 Shaping the reticular ER: the role of RTN/DP1  
 
Proteins firstly identified as necessary and sufficient to ER biogenesis and tubulation 
belonged to the RTN and DP1 families [71]. These proteins are ubiquitously expressed and 
mainly localize in the ER membranes. In particular, members of the two families have been 
shown to be highly enriched in ER tubules, whereas they are excluded from cisternae and 
nuclear envelope, even when overexpressed. Both topology and oligomerization features of 
these proteins have been suggest to contribute to their localization and ability in shaping the 
ER. In fact, RTN/DP1 are both characterized by the presence at their C-terminal domain of 
two long, hydrophobic domains (RDH domain), separated by a hydrophilic region. Each 
transmembrane domain form a hairpin in the lipid bilayer, that is necessary to anchor 
RTN/DP1. Conversely, the N- and the C-terminal and the soluble region remain exposed to 
the ER lumen (Fig. 8) [72]. Deletion of RTN and DP1 genes in yeast and mammalian cells 
results in a great loss in the ER tubules, which convert to a sheet-like appearance [71]. Two 
cooperative mechanisms have been proposed to act in shaping ER tubules. First of all, 
insertion of the hairpin structure in ER bilayer forms a wedge preferentially in the upper part 
of the outer monolayer, causing a local high curvature in ER tubules. Furthermore, 
oligomerization in the lipid bilayer allows the formation of arc-like structures around the 
membranes, consequently forcing them into a tubular shape. Oligomers disassembly is ATP 
dependent, suggesting that they are continuously formed and disassembled, without impairing 
freely diffusion of ER luminal proteins [73]. These findings together suggest that both RTNs 
and DP1 are „„morphogenic‟‟ proteins that are necessary to form and maintain ER peripheral 
tubules, by curvature-inducing and scaffolding mechanisms.  
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6.3 Branching the ER: the role of Atlastins  
 
After the tubules are formed by the curvature-inducing activity of RTN/DP1, tubules are 
connected each other, to form the typical meshwork of three-way junctions. The atlastins 
proteins are involved in the homotypic fusion of adjacent ER tubules [74]. The ATLs are 
integral membrane GTPases belonging to the dynamin family, mainly localized at the tubular 
ER. Two C-terminal TM domains form a hairpin in the membranes, mediating both the 
localization of ATLs and their interaction with RTN/DP1. Indeed, oligomers of ATLs 
associate to RTNs/DP1 at high-curvature regions, interacting from apposing tubules and 
tethering adjacent membranes. Upon coordinated, GTP-dependent, conformational changes, 
ATLs pull the two membranes in close proximity, and insert their amphipathic C-terminal 
into the lipid bilayer of adjacent tubules, destabilizing them and facilitating their fusion [74, 
75]. Depletion of ATLs in mammalian cells results in unbranched ER tubules, whereas their 
overexpression causes the aberrant proliferation of sheet-like cisternae, probably due to the 
excessive fusion of ER membranes [72].    
 
 
 
 
 
 
Figure 8: Molecular model for the generation of ER tubules [72]. 
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6.4 Shaping the cisternal ER: the role of coiled-coil proteins  
 
Morphological differences among ER domains are partially related to variations in membrane 
curvature that enable regulation of domains shape, despite maintaining them physically 
continuous. The peripheral ER cisternae in most species are similar in luminal thickness to the 
tubules, but occur as flat sheet-like structure, curved only at the edge, with a degree of 
curvature similar to ER tubules. It has been demonstrated that curvature-stabilizing proteins 
RTN/DP1 are sufficient to keep the two membranes of a sheet closely apposed, by a wedging 
and scaffolding mechanism, as for ER tubules [76]. However, additional factors contribute to 
stabilize ER sheets. Among these, it has been determined a role for sheet-enriched, coiled-coil 
membrane proteins such as CLIMP63, p180 and kinectin (Fig. 9). CLIMP63, which is the 
best characterized, serves as a luminal spacer, optimizing the size of the luminal space of 
peripheral ER cisternae. In fact, interacting coiled-coil domains of different CLIMP63 
molecules, which extend from apposing membranes of a sheet, control cisternal width [77]. 
By contrast, p180 and kinectin, whose coiled-coil domains are cytosolic, interact with 
cytoskeletal components, anchoring ER sheets to microtubules and contributing to flatten 
their surface. At the same time, localizing at ER sheets, coiled-coil proteins generate an 
“osmotic pressure” that counteracts the shrinkage of cisternae due to the high curvature at the 
edge. Accordingly, coiled-coil proteins are not essential for sheet formation per se, whereas 
RTN/DP1 provide the basic mechanism by which both sheets and tubules are generated [76]. 
Consequently, the cell-type-specific ratio of sheets to tubule in the peripheral ER depends on 
abundance of curvature-inducing proteins and the the relative amount of RTN/DP1 and 
coiled-coil proteins. In agreement, increased expression of RTNs reduces the number of ER 
sheets, whereas its reduction or the overexpression of CLIMP63 cause sheets proliferation 
[76].  
 
 
 
 
 
 
 
20 
 
 
 
6.5 Other factors shaping the ER 
 
Additionally to RTN/DP1 and sheet-enriched proteins, also membrane-bound polysomes 
contribute to ER-sheets shape maintenance. Polysomes enrichment on flat cisternae (Fig. 9) 
participates in concentrating sheet-localized proteins such as translocons and their 
disassembly therefore causes an equally distribution of these proteins between tubules and 
sheets and contribute to reduce the amount of peripheral cisternae, similarly to depletion of 
the sheet-promoting proteins. At the same time, coiled-coil proteins, favoring the enlargement 
of cisternal surfaces, allow more polysomes to bind and distribute, hence stabilizing the RER 
[76].Other mechanisms shaping and stabilizing the ER include interactions with cytoskeleton 
components or other organelles, such as mitochondria. In animal cells, the peripheral ER is in 
close contact with cytoskeleton and tracks along microtubules (MTs) to spread throughout the 
cytoplasm (Reviewed in [65]). Despite microtubules are not required for tubule formation, 
they influence the appearance of ER, as their disruption with the drug nocodazole causes the 
collapse of the reticular ER and its retraction toward the nucleus. Confirming the role of 
cytoskeleton in the regulation of ER morphology, it has also been reported that sheet-
promoting proteins CLIMP63, p180 and kinectin mediate linking and sliding of the ER along 
microtubules, even though the link between coiled-coil proteins and microtubules in the 
regulation of ER morphology remains still unclear. 
 
 
 
 
 
 
Figure 9: Molecular model for the generation of cisternal ER [77]. 
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6.6 Multidomain organization of the ER 
 
As previously described, segregation of the ER into only SER and RER remains simplistic 
because of the existence of multiple specialized subdomains. In the last years, subdomains 
involved in the functional and physical coupling of the ER to almost all other subcellular 
organelles (Fig. 10) have been largely investigated. Moreover, interactions with these 
organelles have been related to the stabilization of ER network, therefore regulating organelle 
shaping and modulating cellular responses. 
 
 
 
 
Figure 10: ER subdomains and specific markers [63]. 
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6.7 The plasma membrane-associated ER  
 
The ER extensively contacts the plasma membrane (PM), being associated to the 20-45% of 
the cytosolic face of the PM, at least in yeast [78]. In yeast and mammalian cells ER-PM 
distance is estimated at a mean spacing of 33nm, therefore excluding ribosomes from this 
interface [78]. These contact sites are important for the regulation of phosphatidyl inositol 
metabolism and constitute a major site of synthesis for phosphatidylserine [79]. Moreover, in 
mammalian cells, the PAM plays a crucial role in calcium homeostasis. In fact, when ER Ca
2+
 
stores are depleted, the ER-localized stromal interaction molecule 1 (STIM1) and the PM 
protein calcium release-activated calcium channel protein 1 (Orai1) interact, promoting Ca
2+
 
influx into the ER [80]. ER dynamics and proteins modulating it are also important to both 
coordinate activities of interacting organelles and to regulate Ca
2+
-homeostasis. Indeed, a 
massive ER remodeling, similar to that induced by RTN/DP1 ablation, has been observed 
upon Ca
2+
 depletion: enlargement of ER cisternae and their association to PM are in fact 
necessary to Ca
2+
 funneling to the ER [78, 81]. 
 
 
6.8 Other organelles contacting the ER 
 
It is now clear that the ER contacts several organelles and can also be involved in organelle 
generation. It has been demonstrated that ER-GOLGI functional interactions take place in the 
secretory pathway. Moreover, very close and stable contacts have been identified between the 
trans-ER regions and trans-cisternal Golgi to sustain a non vescicular-trafficking that 
transports lipids from the ER to the Golgi, maintaining the characteristic composition of the 
latter [82].  
The ER also contacts endosomes and late-endosomes, both coordinating the movements of 
early endosomes with the ER dynamics and regulating the intracellular distribution of late 
endosomes (Reviewed in [70]).  
Additionally, the smooth ER, in particular the pre-peroxisomal compartment, is involved in 
generation of peroxisome[83], which mediate the degradation of long chain fatty acids [84], 
and close contacts between the two membranes have also been found (Reviewed in [63]).  
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7. THE MITOCHONDRIA-ASSOCIATED MEMBRANEs (MAMs) 
 
Subcellular organelles modulate signaling cascades by compartmentalizing second 
messengers such as calcium and therefore modulate the strength, the duration and the 
localization of signals controlling cell activities. In fact, it is not surprisingly that organelles 
interact each other and that their reciprocal positions in the cytosol are organized to allow 
efficient functional coupling. The interaction between the endoplasmic reticulum and 
mitochondria has been extensively investigated in the last years because of the important 
implications on cell metabolism, apoptosis and calcium signaling that these two organelles 
exert. First evidences of a close contact between ER membranes and the mitochondrial outer 
membrane (OMM) date back to the late Fifties [85] and were successively confirmed by 
several groups. Following studies based in subcellular fractionation protocols led to the 
isolation of ER membranes co-purifying with mitochondria [86] that were successively named 
mitochondria-associated membrane (MAM) by Jean Vance, who identified for the first time 
these contact sites as implicated in the exchange of phospholipids between the two organelles 
[52]. More recently, it has been determined that physical, proteinaceous bridges, of 10-25nm 
in length, link ER and mitochondria [87], and that 20% of the mitochondrial surface is in 
contact with the ER [88]. Functional coupling of the organelles at the MAM was further 
confirmed by the finding that at the contact points calcium transfer from the ER to 
mitochondria occurred in a “quasi-synaptic” manner [89], regulating cell metabolism and 
apoptosis onset (Reviewed in [90, 91]).  
Organization of ER membranes in functionally distinct subdomains suggests that mechanisms 
of intra-organelle protein sorting must exist. Known targeting signals direct proteins to the ER 
or mitochondria. By contrast, signals directing proteins specifically to the MAMs have not 
been clearly identified yet. It has been hypothesized that varying degrees of membrane 
curvature could accommodate different proteins such as for the RTNs or CLIMP63 [76]. 
Otherwise, post-translational modifications such as phosphorylation and palmitoylation can 
alter targeting sequences, influencing protein distribution. The transmembrane, ER-resident 
chaperone calnexin (CNX) localizes also at MAMs [92] and its distribution partially depends 
on the phopsphorylation within an acidic cluster recognized by the MAM-localized protein 
phosphofurin acidic cluster sorting protein 2 (PACS2) [93], which therefore regulates the 
amount of CNX at the MAMs or RER [92]. Additionally, palmitoylation of CNX itself and of 
other MAM-proteins such as heme oxigenase-1 and disulphide isomerases TMX and TMX2 
contributes to their targeting. These findings suggest that palmitoylation of cytosolically 
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exposed cysteines could be a new sorting signal for ER membrane proteins [94]. In 
comparison to the relatively stable association of CNX to the MAMs, the localization of 
another MAM-enriched protein, the ER oxidoreductase 1α (Ero1α), is highly susceptible to 
the redox state and oxygen supply. Ero1α mediates the re-oxidation of the ER disulfide 
isomerase PDI, by its flavin adenine dinucleotide (FAD) prosthetic group that transfers 
electrons from cysteines to molecular oxygen. The vicinity of PDI/Ero1α complexes to 
mitochondria would result in the higher availability of mitochondrial ATP and FAD, 
necessary to the efficient oxidative protein folding. Hypoxia leads to the rapid depletion of 
Ero1α from the MAM suggesting that not only post-translational modifications, but also 
changes in oxidizing conditions could alter mechanisms of protein retention into the ER, 
moving ER proteins toward or away from the site where their activity is required [95]. 
Similarly, MAMs lipid composition influences the anchoring of the sigma-1 receptor at these 
sites, where this Ca
2+
-handling protein promotes the fine-tuning of Ca
2+
 exchanges with 
mitochondria [53, 93].  
As previously reported, in the last years different groups identified intra-organelles lipid rafts-
like domains [49, 50].  More recently, technical improvements in subfractionation techniques 
allow to discriminate between PM-derived and intracellular LPs, demonstrating that MAMs 
have the characteristics of a lipid raft and are able to recruit and orientate different signaling 
proteins needed for the ER-mitochondrial crosstalk and tethering [53, 54]. Alterations in 
liquid-ordered structure or protein composition of ER membrane at ER-mitochondria 
interface could thus influence both the physical and functional coupling of the organelles. 
Moreover, the fact that the MAMs are lipid rafts-like domains could explain discording data 
reporting the presence of some proteins, such as presenilins and γ-secretase, at both PM and 
ER/mitochondria [96, 97]. 
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7.1 ER-Mitochondria tethering 
 
Proteinaceous bridges at the contact sites between ER and mitochondria modulate the 
physical tethering of the two membranes. Both organelles are continuously and concertedly 
remodeled by fusion and fission events. Therefore, it‟s not surprisingly that proteins required 
to membrane remodeling, are also involved in ER-mitochondria juxtaposition. To date, a 
function in organelle tethering has been demonstrated for the mitochondrial-shaping proteins 
mitofusin (MFN) 1 and 2, and dynamin-related protein (DRP1). The first direct, physical ER-
mitochondria linkage to be discovered was MFN2 [98]. MFN2 was found to localize both in 
mitochondria and MAMs and to a lower extent in the ER. Mitochondrial MFN2 it is known to 
regulate mitochondrial fusion and morphology. Conversely, at MAMs, MFN2 regulates ER 
shape and tethering to mitochondria by engaging homo- and hetero-complexes respectively 
with MFN2 and MFN1 on the OMM. Both mitochondria [99] and ER [65] interact with 
microtubules and other cytoskeleton elements, that could act both as scaffolds to stabilize the 
interactions between the organelles and to contribute to the coordinated remodeling of ER and 
mitochondria. Accordingly, the cytoskeleton-binding protein Trichoplein/mitostatin (TpMs), 
previously identified as loosely attached to the OMM, has also been found at the ER-
mitochondria interface, where it regulates mitochondrial morphology and juxtaposition to the 
ER in a MFN2-dependent manner [100]. Another direct, physical linker between the two 
organelles has been revealed in yeast, by a synthetic biology screen, but its homolog in 
mammal cell has not been found yet. This complex, named the ER-mitochondria encounter 
structure (ERMES), includes proteins localized in the OMM or at ER surface and at their 
interface [101]. Recently the ERMES complex has been related also to the efficient lipid 
exchange in yeast, confirming the role of MAMs in lipid metabolism and exchange, and thus 
suggesting that protein complexes regulating the structural tethering could also be necessary 
to a functional modulation of MAMs activities [102]. Other MAM-resident proteins such as 
DRP1 and  PACS2 have been implicated in the regulation of ER-mitochondria tethering, by 
modulation of organelle integrity even though they do not take directly part in the physical 
anchoring of the two membranes [90]. Alterations in mitochondrial morphology have been 
associated to altered juxtaposition of the two compartments [98]. The relation between 
organelle morphology and tethering was further confirmed by investigating the role of the 
MAM-protein PACS2. The multifunctional sorting protein PACS2 controls organelles 
apposition because its ablation causes mitochondrial fragmentation and uncouples the 
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mitochondria-ER axis. PACS2 depletion in fact induces the caspase-dependent cleavage of 
the ER- and MAM-localized Bap31, which in turn promotes mitochondrial fission, through 
the recruitment of the dynamin-related protein 1 (Drp1) [103]. Moreover, PACS2-depleted 
cells are less sensitive to apoptotic stimuli based on the exchange of calcium and signals 
between ER and mitochondria [103]. Mitochondria-associated membranes are also enriched 
with molecular chaperones such as calnexin and Bip/Grp78, involved in both regulation of 
protein folding and Ca
2+
-handling and exchange with mitochondria. Among chaperones, an 
indirect role in the regulation of the distance between ER and mitochondria has been revealed 
for the chaperone glucose-related protein 75 (Grp75) [104]. Grp75 is a mitochondrial protein, 
that in the OMM forms a complex spanning the membranes of the two organelles with the 
voltage-dependent anion channel (VDAC) on the mitochondrial side and the IP3R on the ER 
membrane. In this complex, Grp78 indirectly regulates tethering of the two membranes acting 
as a scaffold to promote the physical coupling of VDAC and IP3R and maximize Ca
2+
-
exchange at the ER-mitochondria interface [104]. Concluding, even though great advances 
have been made in the identification of proteins and complexes regulating the physical tether 
or the functional crosstalk between ER and mitochondria (Fig. 11), several other possible 
mechanisms remain still unknown and need to be addressed in the future.  
 
 
 
Figure 11: Tethers between ER and mitochondria [90]. 
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7.2 Functional crosstalk: lipid synthesis and transport  
 
MAMs are characterized by a specialized proteome that determines their structure and 
functions. As described before, this subdomain of the ER was primarily identified for its 
involvement in the storage, exchange and metabolism of different classes of lipids. Proteins 
firstly found in this localization in fact included enzymes associated to lipid synthesis, such as 
the fatty acid CoA ligase 4 (FACL4), used as a MAM marker; phosphatidylserine synthase 1 
and 2 (PSS1, PSS2); the acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT1); the acyl-
CoA:diacylglycerol acyltransferase 2 (DGAT2) and the phosphatidylethanolamine 
methyltransferase 2 (PEMT2) (Reviewed in [105]). Moreover, enrichment in lipids and 
synthesizing enzymes contribute to explain the lipid-rafts like properties of these ER 
subdomains. Synthesis of phosphatidylcholine (PC), that occurs at the MAMs, represents the 
most evident example of the ability of the two organelles to exchange lipids. 
Phosphatidylserine (PS), precursor of PC, is synthesized at MAMs, where PSS1 and PSS2 
activity is focused. PS is then converted to phosphatidylethanolamine (PE) on mitochondria, 
suggesting that a direct transfer from the ER toward mitochondria is necessary. Finally, PE is 
shuttled back to the ER, at the MAMs, where it is further converted into PC by PEMT2 
(Reviewed in [90, 105]). These, and other findings, together suggest that the interface 
between ER and mitochondria has a primarily role in lipids metabolism and exchange.  
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7.3 Functional crosstalk: calcium signaling regulation 
 
Among proteins enriched at the interface between ER and mitochondria, a large group is 
represented by proteins involved in Ca
2+
-handling, comprising channels deputed to the Ca
2+
 
release/uptake and molecular chaperones (Fig. 12). Cytosolic calcium concentration ([Ca
2+
]c) 
in resting conditions is maintained around 100nM, a value significantly lower than in the 
extracellular space (1mM). Low permeability and calcium pumps at the PM guarantee these 
ranges of values. However, rapid cytosolic Ca
2+
 transients occur through Ca
2+
 mobilization 
from internal stores, or inducing the entry from the extracellular space, reaching values 
around 1-2µM. The ER represents the main intracellular calcium store and releases calcium 
through different receptors. The main route inducing calcium release from the ER involves 
the IP3 Receptors (IP3Rs), which bind on their cytosolic side the inositol-1,4,5-triphosphate 
(IP3), successively opening their transmembrane domain and forming a Ca
2+
 channel 
(Reviewed in [106]). Other receptors stimulating ER calcium release are the Ryanodine 
Receptors (RyR), which are activated by the alchaloid ryanodine and by Ca
2+
 itself (Reviewed 
in [106]). Intracellular Ca
2+ 
concentration is tightly regulated because of the several 
implications of this second messenger in cell functions, and several mechanisms assure the 
maintenance of low Ca
2+
 levels (Reviewed in [107]). Among these, a growing attention has 
been addressed to the role of mitochondria as buffering organelles. Physiological, Ca
2+
-
mobilizing stimuli elicit a [Ca
2+
]c rise theoretically insufficient to induce mitochondrial 
calcium uptake, because of the low affinity of mitochondrial Ca
2+
 transporters, varying 
between 10
-6
 and 10
-4
 M. Paradoxically, upon ER Ca
2+
-release, mitochondria could rapidly 
accumulate calcium down the electrochemical gradient of their membranes (-180mV, 
negative inside). This apparent contradiction between the prompt response of these organelles 
and the low affinity of their transporters, led to the formulation of the “hotspot hypothesis” 
[91]. In response to different stimuli, high-Ca
2+
, transient microdomains are formed at the 
interface between ER and mitochondria, where ER releasing channels and mitochondrial 
transporters are enriched. The close apposition between the two organelles allows the 
formation of subcellular domains where the [Ca
2+
]c largely exceed the bulk of cytosolic 
values, therefore meeting the low affinity of mitochondrial transporters and inducing Ca
2+
 
uptake [108]. MAMs therefore represent a privileged region regulating ER-mitochondria 
Ca
2+
-exchange, as also confirmed by the ablation of key proteins localized at these contact 
sites. In fact, cells depleted for these key regulating factors, show altered regulation of the 
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organelle tethering and functional crosstalk, both impacting on the modulation of cell 
metabolism and cell death responses stimulating ER calcium release. To date, a clear relation 
between variations in ER-mitochondria tethering and calcium signaling has been reported as a 
consequence of MFN2 ablation [98]. Also the ablation of MAM-localized, Ca
2+
-regulating 
proteins affects the calcium exchange. Among these (see Figure 14),  the Sigma-1 Receptor, 
PACS2 and the complex including IP3R/Grp75/VDAC, influence calcium signaling at the 
mitochondria-associated membranes, by stabilizing or modulating the activity of involved 
receptors [108]. 
 
 
 
 
 
 
Figure 12: Ca
2+
-handling complexes and apoptosis-regulator factors at the MAMs [90]. 
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7.4 Functional crosstalk: modulation of cell death responses 
 
Transient variations in [Ca
2+
]c trigger several cellular functions including cell proliferation, cell 
metabolism and regulation of apoptotic responses. In physiological conditions, there is a continuous 
transfer of calcium from the ER to mitochondria necessary to the Ca
2+
-dependent activity of the 
mitochondrial enzymes of the tricarboxylic acid cycle. Ca
2+
 supply to mitochondria is hence 
indispensable to ATP production and cellular bioenergetics and survival [106] (Fig. 13). Upon several 
pro-apoptotic insults such as H2O2 and ER stress, an increased flux of Ca
2+
 to the mitochondria is 
observed, impacting on cell survival (Fig. 13). In fact, calcium overload impairs mitochondrial 
functions, by increasing the membrane permeability through the opening of the “permeability 
transition pore” and the release of cytochrome c and other pro-apoptotic proteins (Reviewed in [108]). 
In this view, the spatial proximity mediated by proteins and complexes at the MAMs is necessary to 
the efficient transfer of calcium and apoptotic signals between the two organelles. Similarly, 
conditions that alter ER functioning, including variations in the ER Ca
2+
 concentration ([Ca
2+
]ER) and 
aggregation of unfolded proteins (the so-called ER stress), can modulate the apoptotic response. 
Proteins endogenously localized or recruited upon cell death induction at the ER-mitochondria 
interface, can modulate the effective [Ca
2+
]ER released, thus impacting on the transmission of cell 
death signals to mitochondria. As previously described, sigma-1, and PACS2, at the MAMs, couple 
specific Ca
2+
-channel, partially stabilizing them and regulating Ca
2+
-dependent signaling and 
apoptosis. Similarly several important apoptosis regulators have been described as crucial modulator 
of Ca
2+
-mediated apoptosis. Some BCL-2 family members, besides their localization in mitochondria 
and cytosol, reside also in the ER. It has been demonstrated that these proteins represent key factors in 
tuning Ca
2+
-release and [Ca
2+
]ER, thus influencing apoptosis induction (Fig. 13). The anti-apoptotic 
protein Bcl-2 was the first identified as regulator of Ca
2+
-homeostasis [57]; later on also Bcl-XL was 
found to act in a similar way. Depending on their recruitment on the ER surface, overexpression of 
both proteins decreases resting [Ca
2+
]ER through the destabilization of SERCA pumps on the ER, thus 
enhancing Ca
2+
-emptying (Reviewed in [109]). Moreover, Blc-2 could also interact with the IP3R and 
inhibit IP3-mediated Ca
2+
-mobilization upon apoptosis induction, leading to a reduced Ca
2+
-release in 
the cytosol and a decreased mitochondrial Ca
2+
-entry, therefore limiting the sensitivity to apoptotic 
stimuli ([110]).  
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Similarly, also the ER-localized anti-apoptotic proteins Bax and Bak are implicated in Ca
2+ 
homeostasis, through the elevation of the resting [Ca
2+
]ER [58]. Indeed, cell depleted for both these 
proteins were more resistant than WT to apoptosis due to the reduction in ER releasable Ca
2+
. 
Together these findings suggested that pro- and anti-apoptotic factors, besides their role at the 
mitochondria, could also regulate the apoptotic response localizing at the ER. In this localization, they 
alter the ER Ca
2+
-content, hence influencing both calcium exchange and functional crosstalk between 
ER and mitochondria. Also cytosolic factors could be recruited at the ER-mitochondria interface to 
regulate the activity of Ca
2+
-channels (Fig. 13). Among these, it has been demonstrated that the 
complex including the anti-apoptotic AKT/PKB kinase [111], the tumor-suppressor PML 
(promyelocytic leukemia protein) and the phosphatase PP2a (protein phosphatase 2a) [112], regulates 
the phosphorylation status and consequently the activity of IP3R3. Active AKT, in response to survival 
signals, distributes on MAMs and hyperphosphorylates the IP3R3, inactivating it and reducing ER 
calcium release and apoptosis induction. Conversely, PML, interacting with AKT and the phosphatase 
PP2a, recruits PP2a which in turn reduces the amount of phosphorylated and active AKT, therefore 
restoring activation of IP3Rs and sensitivity to apoptosis. Another condition that induces Ca
2+
-release 
from the ER and the Ca
2+
-dependent ER-mitochondria crosstalk is the so-called ER stress. Conditions 
saturating the folding capacity of the ER and thus causing the accumulation of unfolded proteins are 
 
Figure 13. ER-mitochondria Ca
2+
-exchange in physiology and apoptosis [91]. 
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referred to as ER stress (Reviewed in [113]). Several physiological stimuli, as well as pharmacological 
treatments or depletion of ER Ca
2+
 stores, induce ER stress. Different feedback mechanisms control 
the efficiency and fidelity of protein folding, activating a series of adaptive signaling pathways when 
ER homeostasis is altered. These adaptive responses are collectively defined the unfolded proteins 
response (UPR), which activates an ER-to-nucleus signaling pathway leading to the attenuation of 
global translation, although synthesis of chaperones is conversely increased to improve ER folding 
capacity  (Reviewed in [114]). Three converging pathways are activated upon ER stress and they are 
mediated by the three sensors IRE1α (inositol requiring kinase α), ATF6 (activating transcription 
factor 6) and PERK (protein kinase-like ER kinase) (Fig.14). These signaling pathways also increase 
cell proteolytic ability, through the activation of autophagy or retrotranslocation of unfolded 
polypetides into the cytosol to proteasomal degradation (Reviewed in [113]). However, these 
cytoprotective responses fail when the ER stress persist, therefore switching to cell death induction. 
The induction of an ER stress-dependent apoptosis has a mandatory mitochondrial phase which is 
activated by the transfer of Ca
2+
 from the ER to mitochondria and consequent mitochondrial Ca
2+
-
overload (Fig. 13). Efficient ER-mitochondrial coupling and Ca
2+
- exchange through the IP3R-VDAC 
complex are therefore essential to apoptosis induction. In agreement, PML depleted cells, whose IP3Rs 
are inactive due to the increased activity of AKT, show increased resistance upon treatment with the 
ER stressors thapsigargin and tunicamycin, and to calcium-dependent apoptosis induced by H2O2 
[112]. Moreover, the role of ER-to-mitochondria communication in ER stress-mediated cell death has 
been further corroborated by the findings that BH3-only, pro-apoptotic members of the BCL-2 family, 
which are retrieved in the ER, can activate a particular branch of the ER stress signaling pathway 
mediated by IRE1α, which in turn promotes the Ca2+-dependent sustained JNK activation and 
apoptosis (Fig. 14) [56, 115].  
 
 
Figure 14: Cell fate decisions under ER stress [114] 
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AIM OF THE PROJECT 
 
Caspase-8 and FADD are components of the DR-signaling. Besides their localization in the 
cytosol or their recruitment in lipid-rafts at the plasma membrane upon apoptosis induction, in 
the last years, several groups have observed the distribution of procaspase-8/caspase-8 and 
FADD in local complexes associated to mitochondria and ER, organelles critically involved 
in regulation of cell death. Existence of these complexes and cleavage of local substrates 
could therefore explain the described ability of these proteins to modulate several apoptosis-
independent pathways. c-FLIP is the best characterized caspase-8 inhibitor. In our group, in a 
c-FLIP overexpressing transgenic mouse model, this protein has also been observed in 
association with mitochondria (unpublished data). Therefore, as first aim of the present study, 
in collaboration with Luca Scorrano (Venetian Institute of Molecular Medicine), we 
investigated the subcellular localization of endogenous c-FLIP. Surprisingly, we found that c-
FLIPL was retrieved at the ER and MAMs, an ER subdomain physically and functionally 
coupled to mitochondria. This novel and unexpected localization prompted us to investigate 
the functional involvement of c-FLIPL in regulation of organelles morphology and ER-
mitochondria crosstalk, using as experimental models c-FLIP
-/-
 and WT MEFs. As second aim 
of this study, we therefore evaluated ER and mitochondria integrity in these cell lines by both 
morphological and biochemical analysis. Moreover, since the ablation of proteins enriched at 
MAMs is often associated to alterations in the ER-mitochondria distance and consequently in 
the exchange of Ca
2+
 and pro-apoptotic signals between these two organelles, as third aim of 
this project we investigated c-FLIP role in the regulation of both ER-mitochondria physical 
tethering and functional crosstalk. To this aim, we explored Ca
2+
 signaling and apoptotic 
responses to ER stress, in WT and c-FLIP depleted cells.  
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RESULTS 
 
 
1. c-FLIPL localizes at the ER and MAMs 
 
Components of the extrinsic apoptosis machinery such as FADD and procaspase-8/caspase-8 
have been primarily described as cytosolic or recruited in complexes at the plasma 
membranes. In the last years however, these proteins have also been found associated to 
nucleus, mitochondria and ER as described in the introduction section. Similarly c-FLIP, the 
principal caspase-8 inhibitor has been described as mainly cytosolic and more recently as 
nuclear. To better determine the subcellular localization of endogenous c-FLIP, we 
investigated its distribution in isolated purified fractions from mouse liver (Figure 1A-B). We 
firstly evaluated cross-contaminations probing each fraction for an organelle specific marker 
(Figure 1A). Under our experimental conditions, purified mitochondria showed as expected 
an enrichment in the mitochondrial translocase of the outer membrane (TOM20), which was 
absent in fractions derived from ER, MAMs and cytosol. MAMs were identified by the 
specific marker fatty acid-CoA ligase 4 (FACL-4). Calnexin (CNX), as expected, was 
enriched in the light membranes (ER+LM) fraction, that mainly contains membranes from 
ER, and MAMs [94]. Finally, the cytosolic marker Lactate dehydrogenase (LDH) was only 
present in the correspondent fraction from cytosol. As shown in Figure 1B, we identified c-
FLIPL in the ER+LM and MAMs fractions, besides the well documented localization in the 
cytosol, whereas it was not detectable in purified mitochondria. Moreover, cleavage 
fragments of this protein were mainly found in the cytosol. By contrast, we didn‟t clearly 
identify the localization of c-FLIPS,R in any fraction, even though, according to our results and 
data from literature, these short isoforms seemed to mainly reside in the cytosol. The novel 
subcellular localization for c-FLIPL prompted us to investigate its functional role in the 
regulation of ER-mitochondria axis. To this aim, we used immortalized mouse embryonic 
fibroblasts (MEFs) derived from the lethal c-FLIP knockout mouse model [25] and their WT 
counterparts. To confirm whether c-FLIP was similarly distributed in our model, WT MEFs 
were fractionated. Purified fractions from cell culture are usually less easily obtained, because 
of technical difficulties. For this reason we investigated c-FLIPL localization only in ER+LM, 
cytosol and crude mitochondria. c-FLIPL distribution was confirmed in ER and cytosol, and it  
was also identified in crude mitochondrial fraction that contains the ER- and MAM-localized 
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CNX (Figure 1C). Subcellular distribution of c-FLIP in the ER and ER-mitochondria contanct 
points of WT cells was also confirmed by immunofluorescence and confocal analysis. In 
Figure 1D representative confocal images of WT MEFs were shown. Mitochondria were 
revealed using the specific pDsRed2-mito plasmid, whereas antibodies against c-FLIP and the 
ER marker calreticulin (CRT) were used. In the upper panel, we reported the co-localization 
between ER and mitochondria. Yellow discrete areas represented overlapping regions of the 
two organelles. Similarly to CRT, c-FLIP displayed a patchy staining in discrete areas of 
mitochondria (middle panel), therefore confirming its localization at the ER-mitochondria 
contact points. Conversely, a wider co-localization between the reticular CRT and c-FLIP was 
shown in the lower panel. Taken together, our findings suggest a novel and unexpected 
localization for c-FLIPL at the ER and MAMs. Furthermore, the localization of DISC 
components at the ER-mitochondria interface indicate that these regions could be involved in 
the regulation of both apoptotic and non-apoptotic death receptors-mediated cellular 
functions. 
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Figure 1. c-FLIPL localizes at the ER and mitochondria-associated membranes. (A) 
Proteins (20 µg) from Percoll-purified subcellular fractions of mouse liver, were separated 
by SDS–PAGE and immunoblotted with the indicated antibodies. (B) Localization of 
endogenous c-FLIP isoforms and cleavage products in subcellular fractions from mouse 
hepatocytes. (C) Western blot of the indicated proteins in subcellular fractions from WT 
MEFs. (D) Representative confocal images of WT MEFs transfected with the indicated 
plasmids. Cells were fixed and immunostained to detect the endogenous c-FLIP. Boxed 
areas are magnified 3. 
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2. c-FLIP depletion results in an altered ER morphology, but intact mitochondria 
 
Ablation of MAMs localized proteins such as MFN2, PACS2 and PERK has shown to alter 
morphology of both ER and mitochondria, hence influencing the functional and physical 
coupling of the two organelles. We investigated the role of the ER- and MAM-localized long 
isoform of c-FLIP in ER and mitochondrial morphology. To this aim we performed three-
dimensional (3D) reconstructions of volume rendered confocal stacks of mitochondria- and 
ER-targeted fluorescent proteins comparing c-FLIP
-/-
 and WT MEFs. As shown in Figure 2A, 
evaluating length and morphology of mitochondria specifically stained with red fluorescent 
protein (MTRFP), we did not observe significant differences in mitochondrial morphology 
and distribution between WT and c-FLIP
-/-
 MEFs. Integrity of the mitochondrial network was 
also verified by evaluating the total ATP production (Figure 2B), which was similarly 
produced by both cell lines. Similarly, we did not observe any evident difference in the 
morphology of Golgi apparatus as shown in Figure 2C. By contrast, we noted an evident 
alteration in ER morphology of c-FLIP
-/-
 MEFs, when compared to WT counterparts. In WT 
MEFs, the ER appeared as a network of interconnected tubules and cisternae, spanning the 
whole cytosolic area. Instead, c-FLIP depleted cells showed a deranged ER, which appeared 
fragmented and characterized by enlarged cisternae, with an apparent increase in the cisternal 
versus reticular ER ratio (Figure 2D, upper panels). We also demonstrated the involvement of 
c-FLIPL in regulation of ER shape, by re-expressing c-FLIPL in c-FLIP
-/-
  MEFs. As shown in 
the lower panels in Figure 2D, whereas transfection of c-FLIP
-/-
 MEFs with a control empty 
vector (EV) did not induce amelioration of ER structure, re-expression of c-FLIPL (c-FLIP) 
partially corrected ER morphology of c-FLIP
 
ablated cells, as supported by both 
morphological analysis of 3D-reconstructed and volume rendered confocal images. 
Alterations in ER morphology were further confirmed evaluating the ER luminal contiguity 
by fluorescence recovery after photobleaching (FRAP) of ER-targeted yellow fluorescent 
protein (ERYFP). In Figure 2E, we reported  that fluorescence recovery of photobleached 
ERYFP proceeds much more slower in c-FLIP
-/-
 MEFs than in WT cells, suggesting that 
when c-FLIP is ablated, at cell periphery, the ER organized in large cisternae lacks luminal 
contiguity. Conversely, when we evaluated the recovery of fluorescence of ERYFP in the 
perinuclear region, where ER cisternae are usually more distributed, as expected we did not 
observe significant changes in the luminal contiguity of c-FLIP
 
ablated cells, indicating that 
ER defects mainly affected its organization at the periphery  (Figure 2F). Again, the re-
38 
 
introduction of c-FLIPL in ablated MEFs, partially recovered the phenotype observed in c-
FLIP
-/-
 cells. Altogether these data indicate a role for c-FLIPL in regulation of ER dynamics 
and structure. Our results suggest that c-FLIPL is critical for ER shaping and integrity, 
whereas other organelles such as mitochondria and the Golgi are not significantly affected by 
c-FLIPL ablation. 
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Figure 2. c-FLIP ablation alters ER morphology and luminal contiguity, 
but not mitochondria and Golgi apparatus. (A) Top: representative 3D-
reconstructions of mitochondria in MEFs of indicated genotype transfected with MTRFP. 
Bottom: mean±s.e.m. (n=4, 25 cells per experiment) of data from A. (B) Total cellular ATP 
levels were measured in cells of the indicated genotype. Data represent mean±SEM of 3 
independent experiments. MTRFP, mitochondria-targeted ref fluorescent protein. (C) 
Representative 3D-reconstructions of Golgi apparatus in MEFs of indicated genotype stained 
with the GM130 antibody. 
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Figure 2. Figure 2. c-FLIP ablation alters ER morphology and luminal contiguity, but 
not mitochondria and Golgi apparatus. (D) Representative 3D-reconstructions of ER in 
MEFs of indicated genotype co-transfected with ERYFP and the indicated plasmids. In the 
upper panels, ER morphology of WT and c-FLIP
-/-
 MEFs was reported. In the lower panel, 
ER structure of c-FLIP
-/-
 cells transfected respectively with c-FLIPL and the empty vector 
(EV) was evaluated. 
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Figure 2. Figure 2. c-FLIP ablation alters ER morphology and luminal contiguity, but 
not mitochondria and Golgi apparatus. (E) Left: Fluorescence recordings from real-time 
sequence of ERYFP FRAP in c-FLIP
-/-
 and WT MEFs, in the cell periphery. Right:  
Mean±s.e.m (n=5, 10 cells per experiment). (F) Fluorescence recordings from real-time 
sequence of ERYFP FRAP in c-FLIP
-/-
 and WT MEFs in the perinuclear regions. 16 μm2-
regions were photobleached for a total of 3 s, using 100% laser power of the 488nm. EV, 
empty vector. FRAP, fluorescence recovery after photobleaching; ERYFP, ER-targeted 
yellow fluorescent protein; 
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3. Alterations in ER-shaping proteins in c-FLIP-/-  MEFs  
 
Morphological alterations of c-FLIP
-/-
 MEFs prompted us to evaluate the involvement of ER-
shaping proteins that are known to regulate ER dynamics. In fact, in most cells the ER is 
usually composed of a mixture of interconnected tubules and cisternae and the balance 
between tubules and sheets largely depends on the relative amount of RTNs/DP1 and sheet-
enriched proteins such as CLIMP63. We firstly analyzed the expression levels of ER-
localized proteins in total lysates to discriminate whether the apparent increase in cisternal ER 
in c-FLIP
-/-
 MEFs could be due to an extensive expansion of the entire organelle. As 
documented in Figure 3A, we did not detect significant differences in the ER markers, Bap31, 
CNX, CRT and FACL-4. We therefore wondered if the observed defects in ER morphology, 
could be associated to variations in the expression levels of ER shaping proteins. 
Consequently, we evaluated by WB the expression of the ER-shaping protein RTN4, the best 
characterized member of RTNs family, and that of CLIMP63, an ER-sheet resident protein 
involved in regulation of cisternal ER. We isolated purified fractions from WT and c-FLIP
-/-
 
MEFs and probed them for cross-contaminations from mitochondrial and cytosolic 
components as previously described (Figure 3B). In Figure 3C, we evaluated the expression 
of RTN4 isoforms A and B and that of the coiled-coil protein CLIMP63 in ER+LMs fractions 
isolated from both cell lines. As shown, expression of both reticulon-4 isoforms is reduced in 
c-FLIP
-/-
 with respect to WT cells. By contrast, we did not note variations in expression levels 
of the coiled-coil protein CLIMP63 between WT and c-FLIP
-/-
 MEFs. Densitometric analysis 
reported in Figure 3D, confirmed that c-FLIP
-/-
 MEFs presented a lower amount of RTN4 
isoforms than WT. Nevertheless, even though an increase in CLIMP63 could not be observed 
in our model, the unbalance in the RTNs:CLIMP63 ratio could contribute to explain ER 
defects and the altered equilibrium between reticular ER and ER sheets in c-FLIP
-/-
 MEFs. 
We also compared the expression of Atlastins (ATLs), another family of ER shaping proteins, 
which promote the fusion of adjacent ER tubules and whose down-regulation primarily 
affects Golgi morphology. Accordingly to the intact morphology of Golgi apparatus, WB 
analysis reported in Figure 3E did not reveal any significant differences in the expression of 
ATLs isoforms 1 and 2 between WT and c-FLIP
-/-
 MEF. A slight reduction in ATL3 was 
observed in c-FLIP
-/-
, even though being these three isoforms functionally redundant, we 
hypothesized that the observed reduction in ATL3 expression was not significant. Taken 
together, these results hypothesize that alterations in the expression of curvature-inducing 
proteins such as RTNs could be involved in the regulation of dynamics and tubulation of ER 
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in c-FLIP
-/-
 MEFs, thus confirming that the enlargement of ER sheets observed in c-FLIP 
ablated cells could be associated to an unbalanced RTNs:CLIMP63 ratio. Moreover, our 
findings hypothesize for the first time that a caspases inhibitor is able to affect ER shaping, 
probably by modulating the cleavage and stability of ER-shaping proteins.  
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Figure 3. Altered ER morphology in c-FLIP
-/-
 is associated to variations in ER-shaping 
proteins levels. (A) Total lysates (50µg) from WT and c-FLIP
-/-
 MEFs were separated by 
SDS-PAGE and blotted for different ER markers. Β-actin was used to normalize. (B) 
Proteins (20µg) from crude mitochondria, endoplasmic reticulum (ER+LMs) and cytosol 
fractions of WT and c-FLIP
-/-
 MEFs were prepared and cross-contaminations were evaluated 
as reported in Figure 1C.  
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Figure 3. Altered ER morphology in c-FLIP
-/-
 is associated to variations in ER-
shaping proteins levels. (C-D) Western Blot and densitometric analysis of expression 
levels of reticulon4 isoforms (RTN4A,B) and CLIMP63 in ER fractions from WT and c-
FLIP
-/- 
MEFs. (E) Expression levels of atlastin isoforms 1,2,3 (ATL1,2,3) in ER fractions 
were evaluated by WB analysis. Bap31 was used as normalizer. (*p≤0,001. **p≤0,0001) 
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4. Lack of c-FLIPL alters the ER-mitochondria tethering  
 
As previously described, ablation of c-FLIP in MEFs altered the ER structure, probably due to 
variations in RTNs levels. The unexpected localization of c-FLIPL at the ER and MAMs and 
its role in the regulation of ER morphology, prompted us to address whether c-FLIPL could 
also contribute to the ER-mitochondria tethering. Semi-quantitative confocal microscopy 
analysis of volume-rendered 3D reconstructions of z-axis stacks of confocal images of 
ERYFP and MTRFP were used to measure the juxtaposition between ER and mitochondria. 
As shown in Figure 4A, in WT MEFs (top panels, on the left) several yellow areas, that 
indicate the co-localization of the two organelles, were noticeable. Moreover, the 
interconnection between mitochondria and the ER network was evident. Conversely, tethering 
of the two organelles was reduced in c-FLIP
-/-
 MEFs (top panels, on the right), in which ER 
and mitochondria overlapped to a lower extent. c-FLIPL re-expression in ablated cells 
corrected tethering of c-FLIP
-/-
 MEFs, whereas no changes in organelle juxtaposition were 
observed in c-FLIP
-/- 
transfected with the empty vector (EV). We quantified the ER-
mitochondria juxtaposition calculating the Manders‟ colocalization coefficient [116], a 
method to measure the degree of co-localization of objects in confocal dual-colour images, 
and get quantitative information about the positional relation between two biological objects. 
By this procedure, we revealed a statistical significant, ~20% reduction of the ER-
mitochondria tethering in c-FLIP
-/-
 MEFs, that was counterbalanced by c-FLIPL 
reintroduction (Figure 4C). We further confirmed the reduced ER-mitochondria tethering, by 
comparing the contamination of crude mitochondria by light membranes (LMs). To this aim, 
we used mitochondria isolated from c-FLIP
-/-
 and WT MEFs and probed them for the ER 
marker CNX. Accordingly with our previous result, as reported in Figure 4A, crude 
mitochondria from c-FLIP
-/-
 contained a lower amount of CNX, thus suggesting that fractions 
from depleted cells were less contaminated by LMs than those from WT probably as a 
consequence of the reduced ability of the two organelles to interact each other. Altogether, 
our findings suggest that c-FLIPL positively regulates ER morphology and ER-mitochondria 
tethering. 
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Figure 4. c-FLIP regulates mitochondria–endoplasmic reticulum juxtaposition. (A) 3D-
reconstructions of ER and mitochondria in MEFs of indicated genotype co-transfected with 
MTRFP, ERYFP and the reported plasmids. Yellow areas indicate that organelles are closer 
than 270 nm. Scale bar, 50 mm. In the lower panels, c-FLIP indicates the re-introduction of 
c-FLIPL in depleted MEFs; EV indicates the empty vector. (B) Mean±s.e.m. (n=5, 10 cells 
per experiment) of interaction data from B. (C) Western blot of the specified proteins in 
crude mitochondrial fractions isolated from the indicated MEFs. (***p≤0,0001) 
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5. c-FLIP-/-  MEFs are selectively resistant to ER stress mediated apoptosis 
 
ER-mitochondria juxtaposition mediates the apoptotic response to several stimuli, including 
prolonged ER stress, because a local flux of calcium from the ER towards mitochondria 
participates to apoptosis induction. Our results suggest that ablation of c-FLIP leads to the 
disruption of the ER structure, apparently causing dilation of cisternae and fragmentation of 
ER network. ER membranes expansion occurs even during ER stress [117], and the 
concomitant increase in the capacity of this organelle has been related to a reduced sensitivity 
to ER stress inducers [118]. In view of the localization of c-FLIPL at the ER and MAMs, and 
its role in modulation of both ER structure and ER-mitochondria tethering, we also 
investigated its involvement in the ER stress-mediated apoptotic response. To this aim, we 
treated WT and c-FLIP
-/-
 MEFs with two ER stress inducers thapsigargin (TP), that inhibits 
the sarcoplasmic/ER Ca
2+
-ATPase reducing ER Ca
2+
 levels, and tunicamycin (TN), that 
blocks protein N-glycosylation and export from the ER. After 16h treatment, we measured 
TP- and TN-mediated cytotoxicity by the colorimetric MTT assay. Surprisingly, we observed 
that c-FLIP
-/-
 MEFs were less sensitive than WT to prolonged ER stress mediated by both 
stimuli (Figure 5A). Consequently, we evaluated the apoptotic response assessing cleavage of 
caspase-3 and PARP with specific antibodies. As shown in Figure 5B, cleavage of both PARP 
and caspase-3 was more evident in WT cells than in c-FLIP
-/-
 MEFs, confirming the reduced 
sensitivity of the latter. We therefore wondered whether c-FLIP
-/-
 cells could have adapted to 
ER stress modulating the expression of ER stress sensors or that of proteins involved in the 
progression of ER stress response. To this aim, we evaluated the expression of two ER stress 
markers, the chaperone Bip/Grp78 and the transcription factor CHOP/GADD153, whose 
overexpression rapidly take place after ER stress induction. In basal conditions, we did not 
find any noteworthy difference between WT and c-FLIP
-/-
 MEFs neither regarding Bip/Grp78 
levels, nor CHOP/GADD153. In accordance, upon treatment with TP and TN, we observed 
up-regulation of both Bip/Grp78 and CHOP/GADD153 in both WT and c-FLIP
-/-
 MEFs, even 
though the up-regulation occurred to a different extent in these cells in response to TP and TN 
(Figure 5B). Successively, to discriminate whether this increased resistance of c-FLIP
-/-
 cells 
was restricted to ER stress-dependent stimuli, we treated both cell lines with the monoclonal 
antibody activating Fas (JO-2) to activate the extrinsic pathway of apoptosis, and with 
etopside to activate the mitochondrial one. As previously described by Yeh, W.C. et al. [25], 
we confirmed that c-FLIP
-/-
 MEFs were as susceptible as WT cells to stimuli activating the 
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intrinsic pathway, whereas they displayed higher caspase-3 cleavage as compared to WT, 
upon triggering of Fas receptor by its agonist  (Figure 5C). Together, our results indicate that 
the reduced sensitivity to ER stress stimuli in c-FLIP ablated cells does not depend on an 
adaptive down-regulation of ER stress machinery. We can therefore hypothesize that changes 
in ER morphology or in the ER-mitochondria distance driven by c-FLIP absence, could lead 
to a less efficient transmission of apoptotic signals to mitochondria, therefore explaining the 
reduce sensitivity c-FLIP
-/- 
MEFs to TP and TN.  
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Figure 5. Altered ER stress mediated apoptosis in c-FLIP depleted MEFs. (A) MTT 
assay establishing citotoxicity of thapsigargin (TP), 0,1mM and tunicamycin (TN), 1µg/µl 
after 16h of treatment. (B) WB analysis of total lysates (40µg) from MEFs of the indicated 
genotype, upon treatment wit TP and TN. Apoptosis was investigated evaluating cleavage 
of PARP and caspase-3. ER stress induction was measured evaluating up-regulation of 
Bip/Grp78 and CHOP/GADD153. (C) Evaluation of caspase-3 cleavage by WB analysis 
in wt and c-FLIP
-/-
 MEFs treated with JO-2 10µg/ml, for 3h and etoposide (ETO) 0,1mM, 
for 16h. (*p≤0,05) 
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6. Alterations in calcium signaling in c-FLIP depleted cells 
 
It is known that MAMs ensure Ca
2+
-exchange between the ER and those mitochondria that 
reside closely to the ER. In fact, both organelles are enriched in Ca
2+
 signaling elements to 
permit a fine regulation of calcium fluxes at their interface. Apoptotic stimuli such as 
prolonged ER stress induce a rapid Ca
2+
 transfer to mitochondria, where calcium ultimately 
participate to apoptosis induction. We wondered whether the reduced sensitivity of c-FLIP
-/- 
MEFs to ER stress-dependent apoptosis could be related to altered Ca
2+
-exchange between 
the two organelles. To investigate the role of c-FLIP in Ca
2+
 homeostasis in our model, we 
compared Ca
2+
 fluxes in Fura-2-loaded WT and c-FLIP
-/-
 treated with the IP3-inducing agent 
ATP and with thapsigargin, a drug that blocks the SERCA pumps on the ER causing the 
passive discharge of this Ca
2+
 store. EGTA was added to Hanks buffer to perform all 
experiments in Ca
2+
-free conditions and assess only intracellular calcium signaling. We firstly 
stimulated cells with ATP (Fig. 6A), and we observed that the cytosolic Ca
2+
 increase upon 
stimulation was lower and delayed in c-FLIP
-/-  
as compared to WT cells. Likewise, TP-treated 
c-FLIP
-/-
 cells displayed a severely blunted Ca
2+
 release from ER, resulting in a lower increase 
in cytosolic Ca
2+
 with respect to WT counterparts (Figure 6B). TP-dependent passive 
discharge of ER is an indirect evaluation of the ER Ca
2+
 content. Therefore, altered calcium 
signals evoked by TP in c-FLIP
-/- 
MEFs suggested that Ca
2+
 concentration in the ER at the 
steady state was lower in c-FLIP
-/-  
than in WT and it could probably account for the different 
ATP-induced Ca
2+
 release. In conclusion, taken together these findings hypothesize  a role for 
c-FLIP as regulator of Ca
2+
-homeostasis at the ER.    
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Figure 6. c-FLIP ablated cells present altered Ca
2+
 signaling. (A) Fura-2 recordings of 
cytosolic Ca
2+ 
([Ca
2+
]c) after active ER Ca
2+
-release induced by ATP (0,1mM) in MEFs of the 
indicated genotype. Top: Mean±s.e.m. of n=3 recordings.  (B) Fura-2 recordings of cytosolic 
Ca
2+
([Ca
2+
]c) after passive discharge of ER Ca
2+
-stores induced by thapsigargin (0,1mM) in 
MEFs of the indicated genotype. Top: Mean±s.e.m. of n=3 recordings. All the experiments 
are performed in Ca
2+
-free solutions. (***p≤0,0001) 
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7. Increased basal caspase-8 activation in c-FLIP-/- MEFs  
 
It has been previously described that the effector caspase-7 cleaves RTN3 and RTN4B. We 
therefore wondered if the reduced levels of RTN4 observed in c-FLIP
-/-
 MEFs could be 
related to an increased caspase-activity and cleavage. We firstly confirmed by the PMAP 
software the presence of two caspase-cleavage sites in RTN4 sequence (Figure 7A). 
Successively, we compared the basal caspase-8 activation of WT and c-FLIP
-/- 
cells. As 
shown in Figure 7B, we observed an enhanced caspase-8 activation in c-FLIP
-/-
 as compared 
to WT MEFs under basal conditions. Treatment of both WT and c-FLIP depleted cells with a 
specific-caspase-8 inhibitor for 48h induced a reduction of basal caspase-8 activity to levels 
comparable to WT (Figure 7B). We therefore hypothesized that c-FLIP re-introduction in 
depleted cells could similarly reduce activation of caspase-8. In agreement, preliminary 
results suggested that after c-FLIP expression, caspase-8 activity was reduced to levels similar 
to those induced by the specific inhibitor. Taken together these results confirm that ablation of 
c-FLIP in MEFs enhances the basal activation of caspase-8, even though such up-regulation is 
not consistent with apoptosis onset, as deducible by the evaluation of caspase-3 cleavage in 
control conditions reported in Figure 5B. However, increased caspase-8 activity in c-FLIP
-/-
 
MEFs could be sufficient to increase caspase-7 activation, therefore inducing the cleavage, 
and therefore the reduction, of RTN4 in these cells. 
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Figure 7. Caspase-8 activity is increased in c-FLIP
-/-
 cells. (A) Analysis of caspase-
cleavage sites on reticulon-4 sequence using The Proteolysis MAP (PMAP). (B) Caspase-8 
activity was measured in c-FLIP
-/-
 and WT MEFs in basal conditions and after treatment with 
a specific caspase-8 inhibitor (10µM) for 48h. (*p≤0,05. **p≤0,01) 
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DISCUSSION 
 
 
 
During apoptosis, the DISC complex is assembled within LRs on the plasma membrane. 
More recently, several groups independently identified components of the death receptor-
signaling on membranes of both mitochondria and ER, where caspase-8 and FADD interact 
with resident proteins or lipids, forming local complexes. On both these organelles, 
intracellular LR-like microdomains have been detected, therefore suggesting that molecular 
platforms could be formed in these regions in order to locally activate caspase-8 and cleave 
different targets directly where needed. LR-like microdomains localize at the so-called 
MAMs, at the ER-mitochondria interface, and similarly to lipid-rafts in the plasma membrane, 
their liquid-ordered structure is necessary to recruit and orientate signaling complexes 
involved in regulation of cell metabolism, Ca
2+
-homeostasis and apoptosis [54]. In this study 
we investigated the localization of the inhibitor of caspase-8, named c-FLIP, finding out that, 
similarly to caspase-8 and FADD, c-FLIP is not only cytosolic and nuclear as previously 
described, but it also resides in membranous organelles. Indeed, here we demonstrate the 
presence of the long isoform of c-FLIP in the ER and MAMs, but not in isolated 
mitochondria. To our knowledge, it is the first time that c-FLIPL is clearly identified at the 
level of a membranous organelle, even though the existence of a pool of c-FLIP associated to 
intracellular membranes was previously reported by Shain, K.H. et al. [119]. These authors, 
showed that c-FLIPL was predominantly membrane-bound under basal conditions, while it 
increased in the cytosol and in the plasma membrane-associated DISC upon apoptotic 
stimulation, suggesting that the modulation of its distribution could be a crucial mechanism 
for regulating cellular responses to an apoptotic stimuli. Recruitment of c-FLIP to the cytosol 
or plasma membrane upon stimulation could also explain the delay in its identification in the 
ER. In fact, most of the studies regarding c-FLIP have aimed at studying cancer cell death 
after pro-apoptotic treatments, which could in turn cause the re-distribution of c-FLIP from 
membranous organelles to a cytosolic localization. 
ER and mitochondria are largely involved in the regulation of cell death and the importance of 
functional crosstalk between these two organelles is now evident. As previously described in 
the introduction section, several apoptosis regulators localize or are recruited at the ER-
mitochondria interface. Moreover, organelle remodeling and modulation of Ca
2+
-signaling 
influence the exchange of signals between ER and mitochondria and thus the sensitivity to 
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different stimuli. Ablation of proteins resident in the MAMs and/or on the ER/mitochondrial 
side has been often associated to alterations in organelles morphology. In agreement with 
these observation, we demonstrated for the first time that c-FLIP ablation in mouse embryonic 
fibroblasts, derived from the lethal knockout mouse model, caused a dramatic remodeling of 
ER morphology, inducing the enlargement of ER cisternae to the detriment of peripheral, 
reticular ER. Re-introduction of the ER- and MAM-localized c-FLIPL in ablated cells 
partially restored ER morphology, suggesting that the observed phenotype was consequent to 
the depletion of this protein, and not merely correlated to an adaptive response occurred in the 
knockout model.  
In order to investigate the possible molecular mechanism responsible for ER alterations, we 
evaluated at biochemical level the expression of proteins involved in ER remodeling. In 
particular, in c-FLIP
-/-
 cells we observed the reduction of the ER-shaping protein RTN4, 
whereas we did not notice any variation in CLIMP63, the main component of ER cisternae. A 
reduction in ER-shaping proteins such as RTNs, or an unbalance in the ratio between these 
and the coiled-coil proteins such as CLIMP63 have been described to cause alterations of ER 
structure similar to the phenotype observed in c-FLIP
-/-
 MEFs, therefore confirming our 
findings.  
Ablation of proteins and complexes localized at MAMs was also previously reported to alter 
ER-mitochondria tethering, besides organelles morphology. Moreover, it was recently 
demonstrated that yeast strains lacking both components of the tethering complex ERMES 
and tubule-inducing proteins Rtn1p/Yop1 and Rtn1p/Sey1p display reduced ER-mitochondria 
contacts and functional communications [120]. These defects were restored by artificial 
tethering of the two organelles, therefore suggesting that the maintenance of a correct ER 
structure could contribute to both physical tethering and functional coupling of ER and 
mitochondria. In agreement with these former studies, after having demonstrated the 
endogenous localization c-FLIP at MAMs, we observed a reduction in ER-mitochondria 
tethering in c-FLIP
-/- 
cells, which is partially recovered by re-introduction of c-FLIPL. 
However, although we can affirm that restoring c-FLIPL expression in c-FLIP
-/-
 MEFs, ER-
mitochondria vicinity increases, we can only speculate that such increased tethering is 
consequent to the observed recovery in ER structure. Further studies are in fact necessary to 
clarify the connection between ER morphology and tethering to mitochondria.  
It has also been reported that alterations in the ER-mitochondria distance influence functional 
communications between the two organelles. In fact, the depletion of MAM-localized proteins 
such as PACS2 and PERK, uncouples these organelles, therefore reducing the transmission of 
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pro-apoptotic signals to mitochondria and apoptosis onset [103, 121]. In agreement, c-FLIP
-/-
 
cells showed ER-mitochondria uncoupling which correlates with a reduced sensitivity to 
stimuli inducing prolonged ER stress as compared to WT cells. However, differently from 
PACS2 depleted cells, in which the uncoupling of ER and mitochondria compromises ER 
homeostasis, c-FLIP depletion does not induce ER stress. Indeed, basal levels of the ER stress 
sensor Bip/Grp78 did not display differences between c-FLIP
-/-
 and WT cells, indicating that 
the reduced sensitivity of depleted cells was not ascribable to a basal up-regulation of ER 
stress machinery. In addition, both WT and c-FLIP
-/-
 showed a rapid increase in the 
expression of both Bip/Grp78 and CHOP/GADD153 upon ER stress induction, confirming 
the integrity of ER stress-pathways and thus suggesting that a block in the transmission of the 
pro-apoptotic signal to mitochondria, which ultimately execute cell death, has occurred in c-
FLIP
-/-
 MEFs. In response to tunicamycin treatment, up-regulation of both Bip and CHOP in 
c-FLIP
-/-
 cells occurred, even though to lower degree with respect to thapsigargin treatment in 
the same cells. Although both drugs induce ER stress, this discrepancy could be related to the 
mechanism of ER stress induction mediated by different drugs. In particular, tunicamycin 
causes proteins accumulation in the ER by blocking their N-glycosylation and transfer to 
Golgi apparatus. Membrane expansion occurs during ER stress and have been related to the 
increased tolerance to saturation of ER folding capacity [118]. We can therefore hypothesize 
that the basal expansion of rough, cisternal ER in c-FLIP
-/-
 cells could render these cells more 
tolerant to tunicamycin than to thapsigargin treatment, therefore promoting a less efficient or 
a slower up-regulation of ER stress machinery. 
We also observed that Ca
2+
-release evoked by ATP was reduced in c-FLIP
-/-
 MEFs. 
Mitochondrial calcium overload is a potent apoptosis inducer and conditions that reduce the 
transfer of calcium to mitochondria block apoptosis execution. Ca
2+
-handling complexes at 
MAMs influence Ca
2+
-transfer to mitochondria, that is mainly promoted by IP3-receptors. The 
reduced ER Ca
2+
-release observed in c-FLIP
-/-
 could therefore contribute to the increased 
resistance of these cells to prolonged ER stress, because of the lower Ca
2+
-transfer to 
mitochondria. In accordance with this hypothesis, WT and c-FLIP
-/-
 MEFs treated with the 
cytotoxic, anti-cancer drug, etoposide did not display significant differences in the apoptotic 
response, suggesting that the intrinsic apoptotic machinery is intact. We also observed that c-
FLIP
-/-
 cells showed reduced passive ER discharge with respect to WT. This finding 
suggested that c-FLIP
-/-
 cells could have a lower amount of calcium in the ER at the steady 
state, which can in turn account for the reduced IP3-dependent Ca
2+
-release. Such 
hypothesized depletion of ER Ca
2+
-stores in c-FLIP
-/-
 is however contrasting with previous 
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findings reporting that the ER depletion is usually associated to the up-regulation of 
components of the ER stress machinery. Further studies are ongoing to deepen our knowledge 
regarding alterations in Ca
2+
 levels and signaling in c-FLIP
-/-
 MEFs.  
It was previously demonstrated that caspase-7, an effector caspase activated by the apical 
caspase-8, cleaves RTN3 and RTN4B [122]. Moreover, it was also reported that effector 
caspase-3 and -7 exert their functions in different subcellular compartments, being active 
caspase-3 mostly cytosolic and active caspase-7 almost exclusively associated to 
mitochondrial and microsomal fractions [123]. Furthermore, FADD, which acts in the 
recruitment of procaspase-8 to the DISC, has been reported to interact with RTN3, forming an 
ER-bound signaling complex [47]. We wondered if the reduced amount of RTN4 isoforms 
observed in c-FLIP depleted cells could be related to increased caspase-dependent cleavage of 
this protein. We confirmed the presence of caspase-cleavage sites in RTN4 sequence by 
PMAP software. Accordingly to PMAP, the two identified sites are located at N- and C-
terminal of RTN4, which are both exposed to cytosol and are therefore accessible to caspases. 
We also compared basal caspase-8 activation in c-FLIP
-/-
 and WT MEFs, finding out that 
knockout MEFs showed a higher basal activity of caspase-8, as expected in cells lacking the 
principal inhibitor of this caspase. We therefore hypothesize that the increased caspase-8 
activity in c-FLIP
-/-
 cells could indirectly contribute to reduce RTN4 levels by increasing its 
cleavage, probably forming complexes at the ER-mitochondria interface. In agreement, both 
RTN4 itself and CLIMP63 have been reported at the MAMs [55]. We also preliminary 
observed that re-introduction of c-FLIP reduces basal caspase-8 activation to levels 
comparable to those of WT and c-FLIP
-/-
 treated with a specific caspase-8 inhibitor. In 
accordance with our hypothesis, re-expression of c-FLIP leads to the restoration of ER 
morphology and tethering. Additional experiments are ongoing to evaluate the correlation 
between c-FLIPL levels and RTN4 cleavage. Although further studies are necessary to clarify 
the role of caspases in the regulation of organelles morphology, these data together support an 
unexpected role for c-FLIP at the ER-mitochondria interface. We believe that c-FLIP 
represents a novel component of molecular platforms localized at MAMs. The presence of c-
FLIP, as well as that of other DISC components, at ER and mitochondria highlights for DISC 
proteins unexpected roles different from their canonical function as extrinsic apoptosis 
regulators. Since caspase-8 inhibition in the whole cells is not desirable because it would have 
deleterious implications for cell proliferation, we believe that finely controlled caspase-8 
activation could be important for the processing of specific targets where needed. In this view, 
c-FLIP would act as inhibitor of caspase-8 at the MAMs, by regulating the caspase-mediated 
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processing of local substrates. By this local and specific mechanism c-FLIP could therefore 
control ER morphology, ultimately contributing to physical and functional coupling of this 
organelle to mitochondria.  
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MATERIALS AND METHODS 
 
 
Cell culture and transfection 
 
Wild type (WT) and c-FLIP
-/-
 mouse embryonic fibroblasts (MEFs) were a generous gifts of 
Wen-Chen Yeh, Amgen Institute, Toronto, Canada. The MEFs were cultured in DMEM, 
enriched with 10% fetal bovine serum, glutamine (2 mmol/L), sodium pyruvate (1 mmol/L), 
and non-essential amino acids, in the presence of penicillin (100 U/ml) and streptomycin (100 
μg/ml). Transfections whit pDsRed2-Mito (Clontech), pEGFP-ER (Clontech) and pBluescript 
or c-FLIPL plasmid were performed using Transfectin reagent (BIORAD) at 2µg/µl, 
accordingly to the manufacturer‟s instructions. 
 
Subcellular Fractionation 
 
Whole mouse liver or WT and cFLIP
-/-
 MEFs obtained from 4, confluent, 500cm
2
 petri dishes 
were washed twice with PBS, re-suspended in isolation buffer (IB, 200 mM sucrose, 1mM 
EGTA-Tris, and 10 mM Tris-MOPS, pH 7.4), and then broke up by dounce homogenization. 
Accordingly to Frezza C., et al. [124], the homogenized suspension was spun at 800g for 10 
min at 4°C, to pellet nuclei and cell debris;  the supernatant was recovered and further 
centrifuged for 10 min at 10000g, at 4°C. The crude mitochondrial fraction was collected 
from the pellet, whereas the supernatant was further centrifuged for 30 min at 100,000g. The 
resulting pellet, mainly enriched in endoplasmic reticulum (ER), but containing other cellular 
membranes, collectively named light membranes (LM), and the supernatant (cytosolic 
fraction) were spun again at 100,000g for 30 min at 4°C to increase pureness of the two 
fractions. The crude mitochondrial fraction was further purified by resuspending it in a 2X 
volume of IB and then centrifuged three times at 10000g for 10 minutes, at 4°C. Mitochondria 
were finally purified from MAMs contamination by centrifugation at 95000g for 30 minutes 
at 4°C, on a 30% Percoll gradient in IB. The obtained pure mitochondria, recovered as the 
lowest layer on the Percoll gradient, were washed and resuspended in IB. Conversely, MAMs 
were identified as the layer overlying the mitochondrial fraction on the Percoll gradient. 
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Protein concentration was determined by BCA assay (Pierce) and 20 μg of protein were 
separated by SDS-PAGE and immunoblotted for the indicated antibodies as indicated. 
 
Analysis of cell viability 
 
10
4
 WT and c-FLIP
-/-
 MEFs were seeded on 96-wells plate. 24h after the seeding, cells were 
treated with the ER stress inducers thapsigargin (Sigma-Aldrich), 1µM and tuncamycin 
(Sigma-Aldrich), 1µg/µl for 16h. Cell viability was assessed by 3-(4,5-dymethyl thiazol 2-
y1)-2,5-diphenyl tetrazolium bromide (MTT, Sigma-Aldrich), according to [125]. After MTT 
addition in DMEM medium, without FCS, cells were incubated for 4h at 37°C; medium was 
then removed and 100μl of 2-propanol (Sigma-Aldrich) were added to each well to solubilize 
the blue crystals. The OD at 550 nm were then determined for the contents of each well.  
 
ATP measurement 
 
Total ATP levels were measured by using the ATP detection assay system ATPlite 
(PerkinElmer), according to manufacturer‟s protocol. ATP levels were normalized by total 
protein concentration. 
 
Immunoblotting 
 
At the time reported in figures legend, cells were harvested and disrupted in lysis buffer (Cell 
Signaling) in the presence of complete protease-inhibitor mixture (Sigma). Protein 
concentration was determined by BCA assay and the indicated proteins were separated by 
SDS-PAGE, transferred onto polyvinylidene difluoride (PVDF, BioRad) or nitrocellulose 
membranes (Amersham). Membranes were probed using the following antibodies: anti-β-
actin (1:10000, SIGMA); anti-calnexin (1:2000, Abcam); anti-Tom20 (1:10000, Santa Cruz 
Biotechnology); anti-LDH (lactate dehydrogenase, 1:2000, Rockland); anti-FACL4 (1:500, 
Santa Cruz Biotechnology); anti-calreticulin (1:1000; Abcam); anti-cFLIP, Dave-2, (1:800, 
Alexis); anti-RTN4A/B (1:1000, Abcam); anti-CLIMP63 (1:1000, Proteintech); anti-
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Bip/GRP78 (1:1000, BD Bioscience); anti-CHOP (1:1000, Cell Signaling); anti-cleaved 
caspase-3 (1:500, Cell Signaling), anti-PARP (1:1000; Cell Signaling). 
Immunofluorescence 
 
5x10
4
 MEFs of the indicated genotype grown on 24-mm round coverslips, were transfected as 
indicated and fixed after 48h. To visualize c-FLIP and calreticulin distribution, cells were 
fixed for 30 min at RT with 4% ice-cold paraformaldehyde in PBS (pH 7.4), permeabilized 
for 10 min with PBS, 0,2% Triton-100 and blocked for 1 h with the blocking solution PBS, 
10% BSA. Subsequently cell were incubated overnight at 4°C with antibodies for c-FLIP 
(1:100, Abcam) or calreticulin (1:100, Abcam), in PBS, 10% BSA. Primary antibodies were 
revealed incubating for 20 min at RT with an anti-rabbit or anti-mouse IgG conjugated to the 
fluorochrome indicated in the figure legend. For the detection, a Leica confocal microscope 
(Laser Scanning TCS SP2) equipped with Ar/ArKr and He/Ne lasers and with a 40X oil 1.40 
plan apo immersion objective was utilized.  
 
Imaging  
 
For confocal imaging and analysis of the morphology and tethering of ER and mitochondria, 
cells seeded onto 24-mm round glass coverslips and incubated in Hanks balanced salt solution 
(HBSS), supplemented with 10 mM Hepes, were placed on the stage of a Nikon Eclipse 
TE300 inverted microscope equipped with a spinning-disk PerkinElmer Ultraview LCI 
confocal system, a piezoelectric z-axis motorized stage (Pifoc, Physik Instrumente, Germany), 
and an Orca ER 12-bit charge-coupled device camera (Hamamatsu Photonics, Japan). Cells 
expressing ERYFP and/or MTRFP were excited using the 488 nm or the 543 nm line of the 
HeNe laser (PerkinElmer) by using a 60x 1.4 NA Plan Apo objective (Nikon). For confocal z-
axis stacks, images separated by 0.2 μm along the z-axis were acquired. 3D-reconstruction 
and volume rendering of the stacks were performed with the appropriate plugins of ImageJ 
software.  
 
Morphometric and Contact Analysis 
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Analysis of the interactions between ER and mitochondria in WT and c-FLIP
-/- 
MEFs 
expressing MTRFP and ERYFP were performed with ImageJ. Deconvolution, 3D-
reconstruction and surface rendering were realized using the VolumeJ plugin of ImageJ. 
Analysis of the interaction between ER and mitochondria was performed using Manders‟ 
colocalization coefficient [116]. 
 
Fluorescence Recovery After Photobleaching (FRAP) 
 
Cells were plated and transfected with ERYFP as previously described. After 48 h they were 
incubated in HBSS and placed on the stage of a laser scanning microscope (TCS SP5, Leica). 
Using the LasAF software (Leica), 16 μm2-regions were manually defined to be bleached. To 
bleach the YFP fluorescence, 1 z-plane was bleached for a total of 3 s using 100% laser power 
of the 514 nm laser line with a 63X, 1.4NA objective. The post-bleaching images were taken 
at 0,937 s intervals for a total of 120 s. Intensities of the photobleached regions were 
measured and normalized to the intensities of the same region before photobleaching. 
 
Ratiometric measurement of cytosolic Ca
2+
 concentration 
 
15x10
4
 WT and c-FLIP
-/-
 MEFs were seeded on 35mm Petri dishes. 24h after the seeding, 
cells were incubated at 37°C in culture medium containing 3,5 μM Fura2-AM (Invitrogen). 
After 45 min, cells were washed free of Fura2-AM and Hanks balanced solution (HBSS, 
130mM NaCl, 5,2mM KCl, 1mM MgCl2, 10mM glucose, 10mM HEPES, pH 7.4) was added. 
EGTA was added to all solutions. Dishes were placed into a culture chamber at 37°C on the 
stage of an inverted fluorescence microscope (Nikon TE2000E), and connected to a cooled 
CCD camera (512B Cascade;  Roper Scientific). Samples were illuminated alternately at 340 
and 380 nm using a random access monochromator (Photon Technology International) and 
emission was detected using a 510 nm emission filter. Images were acquired (1-ratio image/s) 
using Metafluor software (Universal Imaging Corporation). Calibration was obtained at the 
end of each experiment by maximally increasing intracellular Ca
2+
-dependent fura-2-AM 
fluorescence with 5µM ionomycin, followed by recording minimal fluorescence in a Ca
2+
-free 
medium. [Ca
2+
]I was calculated according to the formulas previously described [126].  
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Evaluation of caspase-8 activity 
 
Caspase-8 activity was measured by the colorimetric FLICE/Caspase-8 Assay kit 
(BioVision). WT and c-FLIP
-/- 
MEFs were plated on 35-mm Petri dishes. 24h after seeding, 
where indicated, 10µM caspase-8 inhibitor (InSolution Caspase-8 inhibitor II, Calbiochem) 
was added in culture medium. 48h later caspase-8 activity was measure according to 
manufacturer‟s protocol. Levels of caspase-8 activation were normalized by total protein 
concentration. 
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